At its May 20, 2026 shareholders meeting, Capgemini SE approved a dividend of €3.40 per share for the 2025 fiscal year, payable from June 4, 2026. The meeting also renewed the terms of key board members including Paul Hermelin and Maria Ferraro, and appointed new directors Véronique Weill and Luc Rémont, enhancing board diversity and expertise. The company maintained its governance structure separating Chairman and CEO roles, with Hermelin reappointed as Chairman. Additionally, the meeting approved executive compensation and auditor appointments, signaling stable leadership and continued focus on governance and sustainability.
The ESR1-mutated metastatic breast cancer market is projected to grow rapidly at a 9.6% CAGR from 2026 to 2036, driven by rising cases of endocrine-resistant HR-positive/HER2-negative breast cancer and advances in precision oncology. Novel therapies ...
At its May 20, 2026 Annual General Meeting, Capgemini SE shareholders approved a dividend of €3.40 per share for 2025, payable from June 4, 2026. The meeting also renewed key board members' mandates, including Paul Hermelin and Maria Ferraro, and app...
Valeo finalized its share buyback program by purchasing 3,325,000 shares at an average price of €11.01 on May 20, 2026. These shares will be used to support employee-related initiatives such as free and performance share plans, employee savings plans...
Exosens plans to double its production capacity for cooled infrared cameras in 2026 to meet growing global demand, especially for long-range surveillance and counter-drone applications. These cameras, made in France, are critical for detecting drone ...
Valeo has completed its share buyback program authorized by its shareholders in May 2025 by acquiring 3,325,000 shares at an average price of 11.01 euros on May 20, 2026. These shares will be used to support various employee-related plans, including ...
